Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma - Ishida, C. T., Zhang, Y., Bianchetti, E., Shu, C., Nguyen, T. T. T., Kleiner, G., Sanchez-Quintero, M. J., Quinzii, C. M., Westhoff, M.-A., Karpel-Massler, G., Prabhu, V. V., Allen, J. E., Siegelin, M. D. (The American Association for Cancer Research (AACR), 2018)
6351588